To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene CDS1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
259 supporting clones for gene CDS1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DB458322 testis .a 1 to 481 8 to 488       488/488
(100 %)
2 diff
(99.6 %id)
DA022319   .a 1 to 493 7 to 499   capped   498/500
(99 %)
1 diff
(99.8 %id)
DA135042 alzheimer cortex .a 1 to 558 2 to 560   tiling clone, capped   559/559
(100 %)
2 diff
(99.7 %id)
AU134712 placenta .a 90 to 586 2 to 498   capped   497/516
(96 %)
3 diff
(99.5 %id)
DA690091   .a 132 to 494 2 to 364   capped   363/363
(100 %)
0 diff
(100 %id)
CB138699 Liver .a 134 to 439 1 to 306       306/306
(100 %)
0 diff
(100 %id)
DN991022 brain, whole brain .a 161 to 872 1 to 712       712/712
(100 %)
5 diff
(99.3 %id)
DA061121 cerebellum .a 166 to 622 2 to 458   capped   457/457
(100 %)
0 diff
(100 %id)
BP271446 small intestine .a 193 to 774 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
CN365942 embryonic stem cells, cell lines H1, H7, andH9 .a 214 to 752 1 to 539       539/539
(100 %)
4 diff
(99.3 %id)
AK314245 ovary, tumor tissue .a 231 to 1851 1 to 1623 exact     1623/1623
(100 %)
2 diff
(99.9 %id)
DB192897 ovary, tumor tissue .a 232 to 738 2 to 511   capped   510/510
(100 %)
3 diff
(99.5 %id)
DB057149 testis .a 253 to 517 2 to 266   capped   265/265
(100 %)
1 diff
(99.7 %id)
AU125076   .a 277 to 1088 2 to 812   capped   811/811
(100 %)
7 diff
(99.2 %id)
DA105575 cerebellum .a 280 to 877 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
DB046817 testis .a 280 to 836 2 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
DB065197 testis .a 283 to 687 2 to 406   capped   405/405
(100 %)
0 diff
(100 %id)
AI264155 Kidney .a 309 to 757 1 to 450     Submitted on the opposite strand 450/450
(100 %)
1 diff
(99.8 %id)
AI262674 adenocarcinoma, colon .a 309 to 507 1 to 199     Submitted on the opposite strand 199/199
(100 %)
0 diff
(100 %id)
AI701631 Kidney .a 309 to 503 1 to 195     Submitted on the opposite strand 195/196
(99 %)
1 diff
(99.5 %id)
AI767212 2 pooled tumors (clear cell type), Kidney .a 309 to 582 1 to 275     Submitted on the opposite strand 275/275
(100 %)
4 diff
(98.6 %id)
AI830639 2 pooled tumors (clear cell type), Kidney .a 309 to 518 1 to 210     Submitted on the opposite strand 210/211
(99 %)
1 diff
(99.6 %id)
AI991484 pooled germ cell tumors .a 309 to 809 1 to 498     Submitted on the opposite strand 498/520
(95 %)
10 diff
(98.1 %id)
BF059653 pooled germ cell tumors .a 309 to 518 1 to 210     Submitted on the opposite strand 210/210
(100 %)
0 diff
(100 %id)
BF108761 pooled .a 309 to 1043 1 to 735     Submitted on the opposite strand 735/736
(99 %)
16 diff
(97.9 %id)
U60808   .a 317 to 2351 1 to 2035 exact tiling clone, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2035/2035
(100 %)
0 diff
(100 %id)
AI221018 placenta .a 327 to 694 1 to 369     Submitted on the opposite strand 369/369
(100 %)
2 diff
(99.5 %id)
AI915679 pooled .a 327 to 576 1 to 252     Submitted on the opposite strand 252/252
(100 %)
6 diff
(97.7 %id)
AI307807 2 pooled tumors (clear cell type), Kidney .a 332 to 916 1 to 584     Submitted on the opposite strand 584/584
(100 %)
1 diff
(99.9 %id)
AI582198 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 332 to 978 1 to 646     Submitted on the opposite strand 646/650
(99 %)
9 diff
(98.7 %id)
AI636223 Kidney .a 333 to 1068 1 to 736     Submitted on the opposite strand 736/736
(100 %)
7 diff
(99.1 %id)
AI635746 Kidney .a 333 to 934 1 to 601     Submitted on the opposite strand 601/601
(100 %)
1 diff
(99.9 %id)
AI635747 Kidney .a 333 to 934 1 to 601     Submitted on the opposite strand 601/601
(100 %)
2 diff
(99.7 %id)
AI942397 Kidney .a 333 to 767 1 to 436     Submitted on the opposite strand 436/436
(100 %)
4 diff
(99.1 %id)
N29532 placenta .a 336 to 810 28 to 493     Submitted on the opposite strand 466/493
(94 %)
20 diff
(96.0 %id)
N29547 placenta .a 345 to 808 12 to 472     Submitted on the opposite strand 461/472
(97 %)
12 diff
(97.5 %id)
W31587 parathyroid gland, parathyroid tumor .a 345 to 661 35 to 346     Submitted on the opposite strand 312/346
(90 %)
6 diff
(98.3 %id)
BU949231 Pancreas, Purified pancreatic islet .a 346 to 942 1 to 597     Submitted on the opposite strand 597/597
(100 %)
4 diff
(99.4 %id)
AI635757 Kidney .a 356 to 905 34 to 583     Submitted on the opposite strand 550/599
(91 %)
6 diff
(99.0 %id)
CN365941 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 372 to 1167 1 to 796       796/796
(100 %)
0 diff
(100 %id)
DA538981 Kidney .a 373 to 960 2 to 590   capped   589/589
(100 %)
2 diff
(99.7 %id)
AW188238 pooled .a 377 to 989 1 to 613   AAA Submitted on the opposite strand 613/614
(99 %)
19 diff
(97.0 %id)
BC074833 Lung, PCR rescued clones .a 417 to 1874 1 to 1458 exact available from MGC,   1458/1458
(100 %)
0 diff
(100 %id)
BC074881 Lung, PCR rescued clones .a 417 to 1876 1 to 1460 exact available from MGC,   1460/1460
(100 %)
0 diff
(100 %id)
AI631148 pooled germ cell tumors .a 468 to 620 1 to 153     Submitted on the opposite strand 153/154
(99 %)
1 diff
(99.4 %id)
NM_001263.3   .a 583 to 4510 616 to 4543 exact RefSeq,   4543/4546
(99 %)
5 diff
(99.9 %id)
BP277284 Kidney .a 602 to 1185 1 to 584       584/584
(100 %)
0 diff
(100 %id)
BE271468 adenocarcinoma cell line, ovary .a 691 to 1265 1 to 580       580/660
(87 %)
14 diff
(97.9 %id)
BM764996 Ascites, stomach .a 721 to 1414 1 to 693       693/693
(100 %)
1 diff
(99.9 %id)
DA459205 tongue, tumor tissue .a 811 to 1387 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
Z21140   .a 824 to 988 1 to 161       161/189
(85 %)
10 diff
(94.8 %id)
CN365943 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 908 to 1490 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
DB238030 trachea .a 1022 to 1625 2 to 605   capped   604/604
(100 %)
0 diff
(100 %id)
CB157789 Liver .a 1074 to 1493 1 to 421       421/421
(100 %)
2 diff
(99.6 %id)
DB240203 trachea .a 1100 to 1686 2 to 588   capped   587/587
(100 %)
0 diff
(100 %id)
FN145813 breast carcinoma .a 1156 to 1244 91 to 3     Submitted on the opposite strand 89/91
(97 %)
0 diff
(100 %id)
CN365944 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 1201 to 1922 722 to 1     Submitted on the opposite strand 722/722
(100 %)
1 diff
(99.9 %id)
AA724395 parathyroid gland, parathyroid tumor .a 1255 to 1722 1 to 468     Submitted on the opposite strand 468/476
(98 %)
1 diff
(99.8 %id)
R27966 placenta .a 1256 to 1618 1 to 376     Submitted on the opposite strand 376/401
(93 %)
17 diff
(95.8 %id)
TI_149289069   .a 1265 to 2049 873 to 95   AAA   779/938
(83 %)
10 diff
(99.0 %id)
BU681537 lung .a 1296 to 2049 767 to 19   AAA   749/750
(99 %)
5 diff
(99.4 %id)
BI056533 placenta_normal .a 1348 to 1654 317 to 12       306/320
(95 %)
6 diff
(98.2 %id)
BP211349 cerebellum .a 1376 to 1973 7 to 604       598/604
(99 %)
7 diff
(98.9 %id)
AW842592 colon_normal .a 1401 to 2057 662 to 10       653/662
(98 %)
6 diff
(99.1 %id)
DA080515 cerebellum .a 1431 to 2017 2 to 588   capped   587/587
(100 %)
4 diff
(99.4 %id)
BP314294 mammary gland .a 1433 to 2015 1 to 583       583/583
(100 %)
2 diff
(99.7 %id)
T11364   .a 1500 to 1692 1 to 194       194/194
(100 %)
4 diff
(98.0 %id)
BX114169 placenta .a 1544 to 2365 823 to 1     Submitted on the opposite strand 823/823
(100 %)
2 diff
(99.8 %id)
AU133598 ovary, tumor tissue .a 1565 to 2263 2 to 700   capped   699/699
(100 %)
0 diff
(100 %id)
R31300 placenta .a 1587 to 1932 1 to 355       355/392
(90 %)
12 diff
(97.0 %id)
AI192361 placenta .a 1599 to 2338 738 to 1       740/738
(100 %)
20 diff
(97.3 %id)
BU608894 Human Lung Epithelial cells, lung .a 1615 to 2351 755 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 737/743
(99 %)
2 diff
(99.8 %id)
AA775446 whole brain .a 1648 to 2351 704 to 1       704/704
(100 %)
4 diff
(99.5 %id)
AI424990 pooled .a 1657 to 2350 693 to 1       693/693
(100 %)
9 diff
(98.8 %id)
DB362784   .a 1719 to 2243 526 to 1       526/555
(94 %)
7 diff
(98.8 %id)
BI791885 Pancreas, Purified pancreatic islet .a 1724 to 2199 1 to 477       477/477
(100 %)
7 diff
(98.6 %id)
AA534169 invasive prostate tumor, Prostate .a 1725 to 2294 8 to 565       558/574
(97 %)
27 diff
(95.3 %id)
BI713640 Pancreas, Purified pancreatic islet .a 1725 to 2352 628 to 1       628/645
(97 %)
11 diff
(98.3 %id)
BQ185833 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1726 to 2343 1 to 618   fully sequenced,   618/618
(100 %)
0 diff
(100 %id)
AA164884   .a 1727 to 2041 1 to 315   fully sequenced,   315/315
(100 %)
0 diff
(100 %id)
CK820792 Pancreas, Purified pancreatic islet .a 1738 to 2329 592 to 1     Submitted on the opposite strand 592/592
(100 %)
0 diff
(100 %id)
TI_158433733   .a 1738 to 2357 681 to 57       625/1011
(61 %)
0 diff
(100 %id)
AW859997 colon .a 1760 to 1894 1 to 135       135/135
(100 %)
6 diff
(95.6 %id)
AW862287 colon .a 1760 to 1894 1 to 135       135/135
(100 %)
6 diff
(95.6 %id)
BU949471 Pancreas, Purified pancreatic islet .a 1762 to 2361 600 to 1     Submitted on the opposite strand 600/600
(100 %)
1 diff
(99.9 %id)
BG435311 placenta .a 1765 to 2361 1 to 596       596/881
(67 %)
9 diff
(99.0 %id)
DA360225 subthalamic nucleus .a 1789 to 2356 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BP350301 brain .a 1789 to 2351 1 to 563   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 563/563
(100 %)
2 diff
(99.7 %id)
CK820791 Pancreas, Purified pancreatic islet .a 1790 to 2346 1 to 557     Submitted on the opposite strand 557/557
(100 %)
2 diff
(99.7 %id)
BI497433 cochlea, ear .a 1805 to 2330 8 to 533       526/533
(98 %)
6 diff
(98.9 %id)
EC580854 Prostate .a 1810 to 1919 1 to 112       112/115
(97 %)
8 diff
(93.1 %id)
EC513208 Prostate .a 1812 to 1906 16 to 110       95/110
(86 %)
6 diff
(94.6 %id)
DB372448 placenta .a 1814 to 2351 535 to 1       535/561
(95 %)
15 diff
(97.4 %id)
AW604838 colon .a 1822 to 2329 1 to 509       509/509
(100 %)
6 diff
(98.9 %id)
AA652534   .a 1828 to 2045 1 to 219       219/219
(100 %)
1 diff
(99.6 %id)
AA773221 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 1830 to 2212 34 to 415       382/420
(90 %)
11 diff
(97.4 %id)
AW604358 colon .a 1852 to 2054 9 to 209       201/215
(93 %)
10 diff
(95.4 %id)
TI_149271945   .a 1861 to 2650 134 to 911     Submitted on the opposite strand 778/1078
(72 %)
23 diff
(97.9 %id)
BU674749 lung, Primary Lung Epithelial Cells .a 1861 to 2502 59 to 698     Submitted on the opposite strand 640/698
(91 %)
6 diff
(99.2 %id)
AW183330 pooled .a 1864 to 2354 491 to 1       491/499
(98 %)
18 diff
(96.4 %id)
BF512765   .a 1864 to 2156 190 to 482     Submitted on the opposite strand 293/482
(60 %)
6 diff
(98.8 %id)
TI_149276375   .a 1868 to 2653 122 to 903     Submitted on the opposite strand 782/903
(86 %)
6 diff
(99.4 %id)
CB853998 lung, Primary Lung Epithelial Cells .a 1868 to 2477 63 to 673     Submitted on the opposite strand 611/673
(90 %)
6 diff
(99.2 %id)
EC494648 Prostate .a 1894 to 2012 1 to 119       119/119
(100 %)
4 diff
(96.7 %id)
EC553017 Prostate .a 1895 to 2012 1 to 115       115/115
(100 %)
3 diff
(97.4 %id)
EC567323 Prostate .a 1896 to 2012 1 to 112       112/112
(100 %)
5 diff
(95.6 %id)
AI912454 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 1907 to 2355 449 to 1       449/449
(100 %)
0 diff
(100 %id)
FN052417 breast carcinoma .a 1910 to 2022 1 to 113       113/114
(99 %)
1 diff
(99.2 %id)
R77853 placenta .a 1939 to 2366 440 to 1     Submitted on the opposite strand 440/440
(100 %)
16 diff
(96.4 %id)
DA386783 thalamus .a 1946 to 2520 2 to 576   capped   575/575
(100 %)
0 diff
(100 %id)
DB379533 placenta .a 1960 to 2351 391 to 1       391/393
(99 %)
2 diff
(99.5 %id)
AW173239 pooled .a 1963 to 2354 392 to 1       392/392
(100 %)
1 diff
(99.8 %id)
BF088934 head_neck .a 1987 to 2163 180 to 4       177/180
(98 %)
0 diff
(100 %id)
EC579991 Prostate .a 1992 to 2102 5 to 110       106/110
(96 %)
10 diff
(91.0 %id)
EC445054 Prostate .a 1993 to 2096 13 to 116       104/120
(86 %)
7 diff
(94.2 %id)
EC501437 Prostate .a 1993 to 2101 1 to 109       109/109
(100 %)
0 diff
(100 %id)
EC574584 Prostate .a 1996 to 2101 11 to 115       105/115
(91 %)
6 diff
(94.8 %id)
R31562 placenta .a 2005 to 2296 301 to 1       301/315
(95 %)
23 diff
(92.7 %id)
AA164885   .a 2011 to 2352 343 to 1   fully sequenced,   343/343
(100 %)
1 diff
(99.8 %id)
BQ184151 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 2015 to 2367 355 to 1   fully sequenced,   355/355
(100 %)
1 diff
(99.8 %id)
AA020760 eye, retina .a 2019 to 2353 335 to 1     Submitted on the opposite strand 335/335
(100 %)
1 diff
(99.8 %id)
FN058786 breast carcinoma .a 2025 to 2144 1 to 120       120/121
(99 %)
1 diff
(99.2 %id)
AI678522 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .a 2027 to 2352 325 to 1       325/325
(100 %)
1 diff
(99.7 %id)
R28219 placenta .a 2033 to 2351 332 to 1     Submitted on the opposite strand 332/332
(100 %)
13 diff
(96.1 %id)
DA386870 thalamus .a 2042 to 2615 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
EC576744 Prostate .a 2071 to 2192 1 to 121       121/121
(100 %)
1 diff
(99.2 %id)
H89005 cochlea, ear .a 2085 to 2356 1 to 277       277/313
(88 %)
6 diff
(98.1 %id)
AI735755 colon .a 2101 to 2346 246 to 1       246/246
(100 %)
2 diff
(99.2 %id)
DB209406 trachea .a 2104 to 2638 2 to 536   capped   535/535
(100 %)
0 diff
(100 %id)
EC557231 Prostate .a 2169 to 2271 1 to 105       105/105
(100 %)
5 diff
(95.3 %id)
DB208495 trachea .a 2183 to 2700 2 to 520   capped   519/519
(100 %)
1 diff
(99.9 %id)
EC560134 Prostate .a 2187 to 2284 1 to 99       99/105
(94 %)
5 diff
(95.3 %id)
BX488042   .a 2191 to 2698 15 to 521       507/521
(97 %)
6 diff
(98.9 %id)
TI_149274142   .a 2243 to 3182 72 to 995     Submitted on the opposite strand 924/1095
(84 %)
24 diff
(97.9 %id)
CB853896 lung, Primary Lung Epithelial Cells .a 2243 to 2981 17 to 754   tiling clone, Submitted on the opposite strand 738/754
(97 %)
6 diff
(99.3 %id)
CA313675 Human Lung Epithelial cells, lung .a 2244 to 2713 1 to 469     Submitted on the opposite strand 469/471
(99 %)
8 diff
(98.4 %id)
CB216231 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 2270 to 2760 1 to 491       491/491
(100 %)
3 diff
(99.4 %id)
CN344503 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2327 to 3063 1 to 736       736/736
(100 %)
2 diff
(99.8 %id)
BI057841 placenta_normal .a 2359 to 2500 141 to 3       139/153
(90 %)
0 diff
(100 %id)
BF514075   .a 2359 to 2754 23 to 417     Submitted on the opposite strand 395/417
(94 %)
6 diff
(98.6 %id)
DA441739 tongue, tumor tissue .a 2369 to 2930 2 to 563   capped   562/562
(100 %)
2 diff
(99.7 %id)
TI_151770516   .a 2376 to 3112 109 to 847       739/1095
(67 %)
13 diff
(98.9 %id)
BM701860 eye, optic nerve .a 2377 to 2805 1 to 428   fully sequenced, Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 428/428
(100 %)
3 diff
(99.3 %id)
TI_149287648   .a 2386 to 3278 957 to 71   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 887/1082
(81 %)
34 diff
(96.9 %id)
BM794389 Ascites, stomach .a 2388 to 3053 1 to 666       666/666
(100 %)
3 diff
(99.6 %id)
FN153855 breast carcinoma .a 2443 to 2541 101 to 3     Submitted on the opposite strand 99/101
(98 %)
0 diff
(100 %id)
AK026697 Human lung .a 2445 to 4498 1 to 2054   tiling clone, available from FLJ, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2054/2054
(100 %)
3 diff
(99.9 %id)
CD367918 Alveolar Macrophage, lung .a 2550 to 3275 744 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 726/726
(100 %)
1 diff
(99.9 %id)
TI_149291227   .a 2563 to 3275 775 to 62   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 714/715
(99 %)
5 diff
(99.4 %id)
CN344502 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 2569 to 3273 1 to 706       706/706
(100 %)
2 diff
(99.8 %id)
BE843975 testis_normal .a 2573 to 3137 7 to 571       565/571
(98 %)
6 diff
(99.0 %id)
BE938558 testis_normal .a 2583 to 3163 1 to 582       582/582
(100 %)
12 diff
(98.0 %id)
BU682059 lung .a 2583 to 3275 712 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 694/694
(100 %)
2 diff
(99.8 %id)
FN077210 breast carcinoma .a 2594 to 2670 1 to 78       78/89
(87 %)
3 diff
(96.7 %id)
GW493365 diffuse (Lauren) gastric adenocarcinoma, stomach .a 2608 to 3011 8 to 411       404/411
(98 %)
6 diff
(98.6 %id)
BE843962 testis_normal .a 2613 to 3164 1 to 550       550/553
(99 %)
17 diff
(97.0 %id)
BQ441443 testis .a 2646 to 3184 1 to 543       543/826
(65 %)
19 diff
(97.7 %id)
FN067246 breast carcinoma .a 2706 to 2786 84 to 1     Submitted on the opposite strand 84/84
(100 %)
3 diff
(96.5 %id)
BM972937 lung .a 2756 to 3278 540 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 522/526
(99 %)
1 diff
(99.9 %id)
BM671026 eye, optic nerve .a 2775 to 3277 519 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 503/503
(100 %)
4 diff
(99.3 %id)
BM928320 brain .a 2777 to 3710 19 to 965       947/1128
(83 %)
40 diff
(96.5 %id)
AI735759 colon .a 2789 to 3272 489 to 6       484/489
(98 %)
0 diff
(100 %id)
AW304313 lung, two pooled squamous cell carcinomas .a 2801 to 3282 482 to 1       482/490
(98 %)
0 diff
(100 %id)
DB523822 testis .a 2824 to 3275 1 to 452     Submitted on the opposite strand 452/452
(100 %)
1 diff
(99.8 %id)
DB509528 testis .a 2856 to 3278 1 to 422     Submitted on the opposite strand 422/422
(100 %)
2 diff
(99.6 %id)
AI188319 placenta .a 2861 to 3279 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AI677654 adenocarcinoma, Pancreas .a 2866 to 3276 412 to 2       411/412
(99 %)
0 diff
(100 %id)
BF064105 colon, colon tumor, RER+ .a 2866 to 3281 416 to 1       416/416
(100 %)
0 diff
(100 %id)
AI769885 2 pooled tumors (clear cell type), Kidney .a 2877 to 3283 407 to 1       407/407
(100 %)
3 diff
(99.3 %id)
AI769145 pooled .a 2878 to 3271 425 to 32   AAA   394/401
(98 %)
0 diff
(100 %id)
AA723627   .a 2935 to 3281 347 to 1       347/347
(100 %)
2 diff
(99.5 %id)
AA021055 eye, retina .a 2949 to 3393 1 to 452     Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 452/453
(99 %)
10 diff
(97.8 %id)
AA781580 parathyroid gland, parathyroid tumor .a 2964 to 3283 322 to 3       320/322
(99 %)
0 diff
(100 %id)
BF037014 adenocarcinoma, ovary .a 3004 to 3722 1 to 722       722/1019
(70 %)
16 diff
(98.5 %id)
AA059040 eye, retina .a 3022 to 3135 1 to 114       114/114
(100 %)
0 diff
(100 %id)
BF000039 colon, colon tumor, RER+ .a 3027 to 3278 267 to 16   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 252/252
(100 %)
2 diff
(99.3 %id)
AI611167 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3037 to 3275 239 to 1       239/239
(100 %)
0 diff
(100 %id)
W56077 parathyroid gland, parathyroid tumor .a 3167 to 3753 1 to 598       598/600
(99 %)
21 diff
(96.5 %id)
BE162225 head_neck .a 3183 to 3393 211 to 1     Submitted on the opposite strand 211/221
(95 %)
8 diff
(96.4 %id)
BE162152 head_neck .a 3203 to 3681 479 to 1     Submitted on the opposite strand 479/483
(99 %)
7 diff
(98.6 %id)
DN915398   .a 3210 to 3775 1 to 565   tiling clone,   565/565
(100 %)
1 diff
(99.9 %id)
EB385394 eye, optic nerve .a 3367 to 4213 1 to 847       847/847
(100 %)
2 diff
(99.8 %id)
AV722360 hypothalamus .a 3547 to 4283 1 to 731       731/742
(98 %)
71 diff
(90.5 %id)
R34781 placenta .a 3624 to 3904 1 to 289       289/295
(97 %)
15 diff
(95.0 %id)
R77997 placenta .a 3624 to 4035 1 to 422       422/424
(99 %)
24 diff
(94.4 %id)
BX106095 placenta .a 3625 to 4355 1 to 731   tiling clone,   731/731
(100 %)
0 diff
(100 %id)
BU950609 Pancreas, Purified pancreatic islet .a 3671 to 4214 1 to 544   fully sequenced,   544/544
(100 %)
3 diff
(99.5 %id)
AV729790 hypothalamus .a 3680 to 4336 1 to 646       646/654
(98 %)
9 diff
(98.7 %id)
AA370451 Prostate .a 3736 to 4011 1 to 276       276/277
(99 %)
1 diff
(99.7 %id)
AW953851   .a 3737 to 4176 1 to 444       444/461
(96 %)
8 diff
(98.3 %id)
AW953855   .a 3737 to 4377 1 to 638       638/639
(99 %)
17 diff
(97.4 %id)
BU622261 Cell Line, Chondrosarcoma .a 3770 to 4498 744 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 728/728
(100 %)
3 diff
(99.6 %id)
AA410685 ovarian tumor, ovary .a 3773 to 4262 1 to 490       490/490
(100 %)
0 diff
(100 %id)
TI_149314693   .a 3819 to 4499 764 to 94       671/981
(68 %)
0 diff
(100 %id)
AA033786 liver and spleen .a 3828 to 4020 1 to 193       193/193
(100 %)
0 diff
(100 %id)
FN061695 breast carcinoma .a 3836 to 3952 1 to 119       119/121
(98 %)
8 diff
(93.4 %id)
BU732641 eye, optic nerve .a 3853 to 4499 664 to 18       647/664
(97 %)
0 diff
(100 %id)
TI_149277106   .a 3877 to 4498 713 to 92   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 622/988
(62 %)
0 diff
(100 %id)
BU677499 lung, Primary Lung Epithelial Cells .a 3877 to 4498 638 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 622/626
(99 %)
0 diff
(100 %id)
TI_149280399   .a 3897 to 4498 701 to 100   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 602/667
(90 %)
0 diff
(100 %id)
BU679187 lung, Primary Lung Epithelial Cells .a 3897 to 4498 618 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 602/610
(98 %)
0 diff
(100 %id)
DN915399   .a 3902 to 4494 593 to 3       591/593
(99 %)
0 diff
(100 %id)
BE504303 carcinoid, lung .a 3936 to 4505 578 to 9   tiling clone,   570/578
(98 %)
0 diff
(100 %id)
AI765853 2 pooled tumors (clear cell type), Kidney .a 3941 to 4499 561 to 3       559/561
(99 %)
0 diff
(100 %id)
AU154858 ovary, tumor tissue .a 3942 to 4498 553 to 1       553/558
(99 %)
7 diff
(98.8 %id)
BG149495 carcinoid, lung .a 3944 to 4499 561 to 6       556/561
(99 %)
0 diff
(100 %id)
BF059302 pooled germ cell tumors .a 3945 to 4497 553 to 1       553/553
(100 %)
0 diff
(100 %id)
AI694777 carcinoid, lung .a 3974 to 4503 540 to 11   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 530/530
(100 %)
4 diff
(99.3 %id)
BE670366 carcinoid, lung .a 3974 to 4504 544 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 531/531
(100 %)
1 diff
(99.9 %id)
CB306214 lung, Primary Lung Cystic Fibrosis EpithelialCells .a 3977 to 4499 540 to 18       523/540
(96 %)
0 diff
(100 %id)
AI760631 2 pooled tumors (clear cell type), Kidney .a 3979 to 4491 531 to 18   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 514/514
(100 %)
6 diff
(98.9 %id)
AI978745 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3980 to 4352 373 to 1       373/373
(100 %)
0 diff
(100 %id)
AW242360 Kidney .a 3980 to 4496 518 to 1       518/518
(100 %)
8 diff
(98.5 %id)
AW242851 Kidney .a 3980 to 4496 519 to 1       519/519
(100 %)
8 diff
(98.5 %id)
BE503109 carcinoid, lung .a 3980 to 4499 521 to 2       520/521
(99 %)
0 diff
(100 %id)
BU607325 Human Lung Epithelial cells, lung .a 4010 to 4498 505 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 489/498
(98 %)
1 diff
(99.8 %id)
CA312281 Human Lung Epithelial cells, lung .a 4017 to 4496 498 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 480/489
(98 %)
0 diff
(100 %id)
DB541991 hippocampus .a 4019 to 4496 1 to 478     Submitted on the opposite strand 478/478
(100 %)
0 diff
(100 %id)
AA633474 breast .a 4023 to 4496 485 to 12   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 474/474
(100 %)
0 diff
(100 %id)
AI432181 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4024 to 4498 475 to 1       475/475
(100 %)
1 diff
(99.8 %id)
AI700568 carcinoid, lung .a 4024 to 4499 477 to 2       476/477
(99 %)
0 diff
(100 %id)
AI637714 pooled germ cell tumors .a 4028 to 4495 468 to 1       468/468
(100 %)
0 diff
(100 %id)
AW302164 Kidney .a 4044 to 4498 455 to 1       455/455
(100 %)
1 diff
(99.8 %id)
AA196790   .a 4053 to 4499 449 to 3       447/449
(99 %)
0 diff
(100 %id)
AA399236   .a 4057 to 4307 14 to 264       251/264
(95 %)
6 diff
(97.8 %id)
AI928519 Kidney .a 4058 to 4497 443 to 6       438/443
(98 %)
0 diff
(100 %id)
AA011413 liver and spleen .a 4061 to 4307 254 to 1       254/255
(99 %)
7 diff
(97.3 %id)
BE673464 Prostate .a 4063 to 4499 439 to 3       437/439
(99 %)
0 diff
(100 %id)
BF437523 Prostate .a 4063 to 4499 438 to 2       437/438
(99 %)
0 diff
(100 %id)
AW770312 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 4071 to 4352 282 to 1       282/282
(100 %)
0 diff
(100 %id)
AI281974 carcinoid, lung .a 4079 to 4505 435 to 9       427/435
(98 %)
0 diff
(100 %id)
AI306156 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 4086 to 4498 413 to 1       413/413
(100 %)
0 diff
(100 %id)
BQ024080 placenta .a 4094 to 4499 423 to 18       406/423
(95 %)
0 diff
(100 %id)
AW418884 2 pooled tumors (clear cell type), Kidney .a 4102 to 4499 400 to 3       398/400
(99 %)
0 diff
(100 %id)
CA313438 Human Lung Epithelial cells, lung .a 4105 to 4498 410 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 394/394
(100 %)
0 diff
(100 %id)
BF432186 pooled .a 4115 to 4491 396 to 20   AAA   377/384
(98 %)
0 diff
(100 %id)
AA059025 eye, retina .a 4120 to 4498 380 to 1       380/383
(99 %)
1 diff
(99.8 %id)
AA523952 colon .a 4120 to 4499 385 to 6       380/385
(98 %)
0 diff
(100 %id)
AA683187   .a 4121 to 4499 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AI915923 Kidney .a 4123 to 4496 370 to 1       370/370
(100 %)
4 diff
(99.0 %id)
AW075563 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .a 4151 to 4499 356 to 8       349/356
(98 %)
0 diff
(100 %id)
AA021007 eye, retina .a 4153 to 4498 375 to 27   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 349/351
(99 %)
3 diff
(99.2 %id)
AA877270 colon, colon tumor RER+ .a 4181 to 4498 318 to 1       318/318
(100 %)
0 diff
(100 %id)
BU950315 Pancreas, Purified pancreatic islet .a 4184 to 4505 323 to 2   fully sequenced,   322/323
(99 %)
6 diff
(98.2 %id)
AW204404   .a 4199 to 4498 315 to 16   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 300/300
(100 %)
0 diff
(100 %id)
AW771341 Kidney .a 4213 to 4497 307 to 22       286/307
(93 %)
0 diff
(100 %id)
AI913892 colon .a 4215 to 4496 282 to 1       282/282
(100 %)
0 diff
(100 %id)
R34679 placenta .a 4272 to 4484 221 to 8       214/221
(96 %)
0 diff
(100 %id)
AI521932 Kidney .a 4276 to 4498 223 to 1       223/223
(100 %)
0 diff
(100 %id)
AI911609 colon .a 4300 to 4491 220 to 29   AAA   192/201
(95 %)
0 diff
(100 %id)
AA370450 Prostate .a 4308 to 4498 191 to 1       191/191
(100 %)
1 diff
(99.5 %id)
AA034044 liver and spleen .a 4350 to 4499 150 to 1       150/150
(100 %)
0 diff
(100 %id)
AY312584 lung carcinoma .b 1 to 543 1 to 541 K6R K7T H8X Y9S R10S ... tiling clone,   541/547
(98 %)
10 diff
(98.2 %id)
AI400183 pooled .c 1 to 563 1 to 563   tiling clone, Submitted on the opposite strand 563/565
(99 %)
20 diff
(96.5 %id)
BG572896 placenta .c 402 to 853 1 to 452   tiling clone,   452/454
(99 %)
1 diff
(99.8 %id)
CN276492 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d-u 1 to 436 1 to 436 E11K tiling clone,   436/436
(100 %)
3 diff
(99.4 %id)
DB328973 placenta Gene CDS1, variant not shown              
DA858902 placenta Gene CDS1, variant not shown       capped      
AV708276 adrenal gland Gene CDS1, variant not shown         Suspected internal deletion, this clone was ignored    
BM770636 Ascites, stomach Gene CDS1, variant not shown         Suspected internal deletion, this clone was ignored    
U65887   Gene CDS1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
CN282226 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells Gene CDS1, variant not shown              
AI673547 colon, colonic mucosa from 3 patients with Crohn'sdisease Gene CDS1, variant not shown              
BX103069 heart Gene CDS1, variant not shown         Submitted on the opposite strand    
R27571 placenta Gene CDS1, variant not shown              
R27669 placenta Gene CDS1, variant not shown              
AA588094 colon, colon tumor RER+ Gene CDS1, variant not shown         Suspected internal deletion, this clone was ignored    
AI160072 heart Gene CDS1, variant not shown         Submitted on the opposite strand    
AI367823 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus Gene CDS1, variant not shown              
AI343398 colon, colon tumor, RER+ Gene CDS1, variant not shown         Suspected internal deletion, this clone was ignored    
AW445185   Gene CDS1, variant not shown       AAA      
CF593967 Human Placenta, placenta Gene CDS1, variant not shown              
DB085872 testis Gene CDS1, variant not shown       capped      
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI